Post-cancer swelling affects thousands of survivors annually, yet many don't know whether their symptoms require specialist intervention or can be managed at home. This guide identifies the specialists who treat lymphedema and treatment-related edema, explains when to escalate care, and provides evidence-based self-management strategies. Key Takeaways Lymphedema is a chronic condition requiring specialist care, while general edema from treatment is often transient and managed

When chemotherapy fails to control metastatic colorectal cancer, treatment shifts from one-size-fits-all to biomarker-driven precision medicine. Molecular profiling of your tumor unlocks targeted therapies, immunotherapy, and trial pathways previously unavailable. Key Takeaways MSI-H or dMMR status determines immunotherapy eligibility; pembrolizumab and nivolumab achieve ~40-50% response rates in this subset RAS wild-type tumors can receive EGFR-targeted therapy (cetuximab, p

Stage 4 pancreatic cancer has spread to distant organs, eliminating surgical options and shifting treatment focus to systemic chemotherapy combined with pain management and supportive care[8]. This guide examines evidence-based chemotherapy regimens, integrated supportive care approaches, realistic survival expectations, and transparent India-specific cost breakdowns to help patients and families make informed treatment decisions. Key Takeaways Systemic chemotherapy, FOLFIRIN

When your oncologist recommends a chemotherapy regimen, the decision reflects a complex clinical framework integrating your cancer type, biomarker test results, disease stage, organ function, and treatment goals. Understanding this decision process empowers you to ask informed questions and participate actively in your care plan. Key Takeaways Chemotherapy regimens are matched to cancer type, FOLFOX for colorectal cancer, AC-T for breast cancer[3], carboplatin-paclitaxel for

Stage 4 cancer pain is manageable through evidence-based interventions, yet many patients endure inadequate relief because they don't know when or how to request escalation. This guide provides actionable steps for accessing specialist care, optimizing medications, exploring interventional procedures, and coordinating multidisciplinary support to achieve better pain control. Key Takeaways Inadequate pain control, frequent breakthrough pain, sleep disruption, or activity limit

Multiple myeloma treatment in Hyderabad demands specialists with autologous bone marrow transplant capability, not just general oncology credentials. This guide evaluates Hyderabad's BMT-equipped myeloma programs using infrastructure, treatment pathways, and cost transparency. Key Takeaways Apollo Hospitals and Yashoda Hospitals maintain the densest evidence of autologous BMT programs for myeloma, with named specialists and documented transplant volumes [5] Autologous bone ma